Association between the respiratory microbiome and susceptibility to influenza virus infection

Clinical Infectious Diseases

Volumn 71, Issue 5, 2020, Pages 1195-1203

  Tsang, Tim K ^a   Lee, Kyu Han ^b   Foxman, Betsy ^b   Balmaseda, Angel ^c,d   Gresh, Lionel ^c   Sanchez, Nery ^c   Ojeda, Sergio ^c   Lopez, Roger ^c,d   Yang, Yang ^a   Kuan, Guillermina ^d   Gordon, Aubree ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Sustainable Sciences Institute   (Nicaragua)

^d Ministry of Health   (Nicaragua)

Author keywords

Influenza; Microbiome; Susceptibility; Transmission

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ARTICLE; BACTERIAL STRAIN; CHILD; CONTACT EXAMINATION; CONTROLLED STUDY; FEMALE; HOUSEHOLD; HUMAN; INFANT; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA B VIRUS; INFLUENZA VACCINATION; INFLUENZA VIRUS; LUNG MICROBIOTA; MAJOR CLINICAL STUDY; MALE; MOUTH FLORA; NASOPHARYNGEAL SWAB; NOSE; POPULATION ABUNDANCE; PRESCHOOL CHILD; PREVOTELLA; PREVOTELLA SALIVAE; PRIORITY JOURNAL; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; STREPTOCOCCUS; STREPTOCOCCUS VESTIBULARIS; THROAT; THROAT SWAB; VIRUS STRAIN; VIRUS TRANSMISSION; FAMILY SIZE; INFLUENZA; INFLUENZA A VIRUS (H3N2); MICROFLORA;

FAMILY CHARACTERISTICS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MICROBIOTA; PREVOTELLA; STREPTOCOCCUS;

EID: 85076523957     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciz968     Document Type: Article

References (40)

1. Iuliano AD, Roguski KM, Chang HH, et al; Global Seasonal Influenza-associated Mortality Collaborator Network. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018; 391:1285-300.
2. World Health Organization. Influenza. In: Immunization, vaccines and biologicals: influenza. 2017. Available at: http://www.who.int/immunization/topics/influenza/en/. Accessed 17 February 2017.
3. Belongia EA, Simpson MD, King JP, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis 2016; 16:942-51.
4. World Health Organization Global Influenza Programme. Seasonal influenza vaccine use in low and middle income countries in the tropics and subtropics: a systematic review [Internet]. Geneva, Switzerland: World Health Organization, 2015. Available at: http://apps.who.int/iris/bitstream/10665/188785/1/9789241565097_eng.pdf. Accessed 19 January 2019.
5. Abt MC, Osborne LC, Monticelli LA, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012; 37:158-70.
6. Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A 2011; 108:5354-9.
7. Levy M, Blacher E, Elinav E. Microbiome, metabolites and host immunity. Curr Opin Microbiol 2017; 35:8-15.
8. Luoto R, Ruuskanen O, Waris M, Kalliomäki M, Salminen S, Isolauri E. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. J Allergy Clin Immunol 2014; 133:405-13.
9. Panigrahi P, Parida S, Nanda NC, et al. Corrigendum: a randomized synbiotic trial to prevent sepsis among infants in rural India. Nature 2018; 553:238.
10. Chao DL, Halloran ME, Obenchain VJ, Longini IM Jr. FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS Comput Biol 2010; 6:e1000656.
11. Monto AS. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev 1994; 16:351-73.
12. Tsang TK, Lau LLH, Cauchemez S, Cowling BJ. Household transmission of influenza virus. Trends Microbiol 2016; 24:123-33.
13. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 2013; 79:5112-20.
14. Lee KH, Foxman B, Kuan G, et al. The respiratory microbiota: associations with influenza symptomatology and viral shedding. Ann Epidemiol 2019; 37:51-56.e6.
15. Gordon A, Tsang TK, Cowling BJ, et al. Influenza transmission dynamics in urban households, Managua, Nicaragua, 2012-2014. Emerg Infect Dis 2018; 24:1882-8.
16. Chen T, Yu WH, Izard J, Baranova OV, Lakshmanan A, Dewhirst FE. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford) 2010; 2010:baq013.
17. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10.
18. Holmes I, Harris K, Quince C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS One 2012; 7:e30126.
19. Morgan M. DirichletMultinomial: Dirichlet-multinomial mixture model machine learning for microbiome data. R package version 1.26.0. 2017. Available at: https://bioconductor.org/packages/release/bioc/html/DirichletMultinomial. html. Accessed 19 July 2018.
20. Cauchemez S, Donnelly CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009; 361:2619-27.
21. Tsang TK, Cauchemez S, Perera RA, et al. Association between antibody titers and protection against influenza virus infection within households. J Infect Dis 2014; 210:684-92.
22. Lee KH, Gordon A, Shedden K, et al. The respiratory microbiome and susceptibility to influenza virus infection. PLoS One 2019; 14:e0207898.
23. Gilks WR, Richardson S, Spiegelhalter D. Markov Chain Monte Carlo in practice. London: Chapman & Hall, 1996.
24. Short KR, Habets MN, Hermans PW, Diavatopoulos DA. Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? Future Microbiol 2012; 7:609-24.
25. Diavatopoulos DA, Short KR, Price JT, et al. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J 2010; 24:1789-98.
26. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002; 186:341-50.
27. Salk HM, Simon WL, Lambert ND, et al. Taxa of the nasal microbiome are associated with influenza-specific IgA response to live attenuated influenza vaccine. PLoS One 2016; 11:e0162803.
28. Langevin S, Pichon M, Smith E, et al. Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study. J Gen Virol 2017; 98:2425-37.
29. Hui AW, Lau HW, Chan TH, Tsui SK. The human microbiota: a new direction in the investigation of thoracic diseases. J Thorac Dis 2013; 5(Suppl 2):S127-31.
30. Cheung MK, Lam WY, Fung WY, et al. Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing. PLoS One 2013; 8:e54574.
31. Xu C, Chan KH, Tsang TK, et al. Comparative epidemiology of influenza B Yamagata- and Victoria-lineage viruses in households. Am J Epidemiol 2015; 182:705-13.
32. Levy JW, Cowling BJ, Simmerman JM, et al. The serial intervals of seasonal and pandemic influenza viruses in households in Bangkok, Thailand. Am J Epidemiol 2013; 177:1443-51.
33. Petrie JG, Ohmit SE, Cowling BJ, et al. Influenza transmission in a cohort of households with children: 2010-2011. PLoS One 2013; 8:e75339.
34. Cauchemez S, Ferguson NM, Fox A, et al. Determinants of influenza transmission in South East Asia: insights from a household cohort study in Vietnam. PLoS Pathog 2014; 10:e1004310.
35. Tsang TK, Fang VJ, Ip DKM, et al. Indirect protection from vaccinating children against influenza in households. Nat Commun 2019; 10:106.
36. Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74.
37. Chen R, Holmes EC. The evolutionary dynamics of human influenza B virus. J Mol Evol 2008; 66:655-63.
38. Cobey S, Gouma S, Parkhouse K, et al. Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13. Clin Infect Dis 2018; 67:327-33. doi: 10.1093/cid/ ciy097.
39. Zost SJ, Parkhouse K, Gumina ME, et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci USA 2017; 114:12578-83.
40. Ruest A, Michaud S, Deslandes S, Frost EH. Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol 2003; 41:3487-93.